Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2011 Nov 11;33(2):279–285. doi: 10.1016/j.cct.2011.11.004

Table 1.

Characteristics of subjects pre-screened for eligibility based on protocol inclusion/exclusion criteria

Prescreening Number(N) Percentage (%)
Total pre-screened 3547
Prostate cancer diagnosis 1596 45
Benign diagnosis 1164 33
ASAP(prior to being added to protocol in year 3) 109 3
Other Cancers 29 0.8
Other illness/Recent abnormal labs prior to screening 75 2
Concomitant medications 37 1
History of GI bleeds 10 0.3
Age >80 years 48 1.4
PSA > 10 18 0.5
Ineligible/Unknown 133 3.8
parameters
Biopsy Pending 112 3.2

Total number eligible for screening visit 216 6.1